Research
Publications
2025
Zhu J, Kim KWR, Yu H, Gupta A, Mushlin AI, Kamel H, et al. Acute Ischemic Stroke Care Quality Improvement. JAMA Neurol. 2025 Jan 13
2024
Jiang S, Guzauskas GF, Garbett S, Graves JA, Williams MS, Hao J, Zhu J, Jarvik GP, Carlson JJ, Peterson JF, Veenstra DL. Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and Polygenic Risk Scores to inform Colorectal Cancer screening. Genet Med. 2024 Sep 30;101285.
2023
Corlis J, Zhu J, Macul H, Tiberi O, Boothe MAS, Resch SC. Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis-with an illustrative case of HIV treatment in Mozambique. Cost Eff Resour Alloc. 2023 Sep 13;21(1):62.
Pandya A, Zhu J. Focusing on Decisions, Outcomes, and Value Judgments to Confront Algorithmic Bias. JAMA Netw Open. 2023 Jun 1;6(6):e2318501.
Zhu J, Kamel H, Gupta A, Mushlin AI, Menzies NA, Gaziano TA, Rosenthal MB, Pandya A. Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness Analysis. Ann Intern Med. 2023 May 2. Online ahead of print.
2022
Zhu J, Pandya A. The Advantages and Nuances of Using Disability-Adjusted Life Years to Characterize Cardiovascular Disease Burden: Insights From Parents and Offspring. Circ Cardiovasc Qual Outcomes. 2022 Dec 9;e009627.
Zhu J, Lyatuu G, Sudfeld CR, Kiravu A, Sando D, Machumi L, et al. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania. Lancet Glob Health. 2022 Nov;10(11):e1646–54.
2022 Top 3 Cost-Effectiveness Analysis Paper of the Year, Tufts CEA Registry
Pandya A, Paulden M, Zhu J, Lavelle TA, Hammitt J. Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates. Med Decis Making. 2022 May 7;272989X221097106.
2021
Chen T, Huang S, Li G, Zhang Y, Li Y, Zhu J, Shi X, Li X, Xie G, Zhang L. An integrated framework for modelling quantitative effects of entry restrictions and travel quarantine on importation risk of COVID-19. J Biomed Inform. 2021 Jun;118:103800.
Gupta S, Zhu J, McCarty TR, Pruce J, Kassam Z, Kelly C, Fischer M, Allegretti JR. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. J Gastroenterol Hepatol. 2021 Sep;36(9):2432–40.
Pandya A, Zhu J, Spahillari A. Cost-effectiveness of Statin Use Guidelines-Reply. JAMA Cardiol. 2021 Mar 1;6(3):364.
2020
He Q, Zhu J, Wang A, Ji K, Ji X, Zhang J, Wu X, Li X, Bu Z, Ji J. A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China. Cancer Med. 2020 Dec;9(23):8940–9.
Spahillari A*, Zhu J*, Ferket BS, Hunink MGM, Carr JJ, Terry JG, Nelson C, Mwasongwe S, Mentz RJ, O’Brien EC, Correa A, Shah RV, Murthy VL, Pandya A. Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. JAMA Cardiol. 2020 Aug 1;5(8):871–80.
(*Co-first authors)
Mason SE, Zhu J, Rahaghi FN, Washko GR, Pandya A. Cost-effectiveness microsimulation of catheter-directed thrombolysis in submassive pulmonary embolism using a right ventricular function model. J Thromb Thrombolysis. 2020 May;49(4):673–80.
2018
Pandya A, Doran T, Zhu J, Walker S, Arntson E, Ryan AM. Modelling the cost-effectiveness of pay-for-performance in primary care in the UK. BMC Med. 2018 Aug 29;16(1):135.
Research Awards / Fellowships
Top 3 Cost-Effectiveness Analysis Paper of the Year | Tufts CEA Registry | 2022
Dissertation Completion Fellowship | Harvard Graduate School of Arts & Sciences | 2021-2022
Harvard China Health Partnership Research Award | Harvard China Health Partnership | 2020
Lee B. Lusted Student Prize Stephen Pauker Award for Quantitative Methods and Theoretical Development |The Society for Medical Decision Making (SMDM) | 2019